FCM
GMED icon

Fourpath Capital Management’s Globus Medical GMED Stock Holding History

Fourpath Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60
Closed -$4.29K – 453
2024
Q3 		$4.29K Buy
+60
New +$4.24K ﹤0.01% 572

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fourpath Capital Management's GMED Position: Q4 2024 in Review

Fourpath Capital Management sold out of Globus Medical (GMED) in Q4 2024, closing a stake of 60 shares — an estimated $4.29K sold.

Fourpath Capital Management first reported a position in GMED in Q3 2024 and held it in 1 quarter. The position peaked at $4.29K in Q3 2024. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • Fourpath Capital Management reported no remaining Globus Medical position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 60 Globus Medical shares in Q4 2024, an estimated $4.29K.
  • Fourpath Capital Management first reported a position in Globus Medical in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Globus Medical position peaked at $4.29K in Q3 2024.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.